InvestorsHub Logo
Followers 10
Posts 782
Boards Moderated 0
Alias Born 02/08/2007

Re: DewDiligence post# 840

Saturday, 05/18/2019 8:11:28 PM

Saturday, May 18, 2019 8:11:28 PM

Post# of 7307
<<pursuing therapeutic indications, such as CD, before obtaining regulatory approval for the first aesthetic indication may well be the plan that maximizes shareholder value. I’m surprised that you and ‘jmk’ seem confident that RVNC is making a mistake. >>

Don't be obtuse Dew. I'm not saying do nothing, I am saying slow the burn and be strategic about what you fund non-cosmetically prior to becoming profitable. Very few have a 5+ year timeline to make money.

I was not happy at all with Browne's last conference call. He said he felt "really good" about the decision to delay filing based on the 100 unit. Great Dan but we are getting hammered and the rest of us feel not so "good". In this last year we have gone from 30's to 12.

It just shows a complete lack of understanding/care for your current supporters/shareholders. Dan admitted the filing timeline in 1H19 was "aggressive". Why be "aggressive" now when there is so much more to do? Your credibility is crucial at this stage.

Could very well be RT002 is a great drug but there is mounting evidence the guy running the show is unfit for the challenge
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RVNC News